PT94575A - Processo para a preparacao de novas citoquinas - Google Patents

Processo para a preparacao de novas citoquinas

Info

Publication number
PT94575A
PT94575A PT94575A PT9457590A PT94575A PT 94575 A PT94575 A PT 94575A PT 94575 A PT94575 A PT 94575A PT 9457590 A PT9457590 A PT 9457590A PT 94575 A PT94575 A PT 94575A
Authority
PT
Portugal
Prior art keywords
derivatives
polypeptides
preparation
mediators
cytokins
Prior art date
Application number
PT94575A
Other languages
English (en)
Other versions
PT94575B (pt
Inventor
Karel Gerrit Odink
Josef Brueggen
Walter Wiesendanger
Nico Cerletti
Lajos Tarcsay
Clemens Sorg
Christiane Dewolf-Peeters
Jan Delabie
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PT94575A publication Critical patent/PT94575A/pt
Publication of PT94575B publication Critical patent/PT94575B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3061—Blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Control Of Transmission Device (AREA)
  • Control Of Driving Devices And Active Controlling Of Vehicle (AREA)
  • Radar Systems Or Details Thereof (AREA)
PT94575A 1989-07-05 1990-07-03 Processo para a preparacao de novas citoquinas PT94575B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898915414A GB8915414D0 (en) 1989-07-05 1989-07-05 Novel cytokines

Publications (2)

Publication Number Publication Date
PT94575A true PT94575A (pt) 1991-03-20
PT94575B PT94575B (pt) 1997-02-28

Family

ID=10659582

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94575A PT94575B (pt) 1989-07-05 1990-07-03 Processo para a preparacao de novas citoquinas

Country Status (14)

Country Link
US (2) US5411882A (pt)
EP (1) EP0412050B1 (pt)
JP (1) JPH0356499A (pt)
AT (1) ATE131873T1 (pt)
AU (1) AU649226B2 (pt)
CA (1) CA2020303A1 (pt)
DD (1) DD298948A5 (pt)
DE (1) DE69024279T2 (pt)
DK (1) DK0412050T3 (pt)
ES (1) ES2081960T3 (pt)
GB (1) GB8915414D0 (pt)
GR (1) GR3018521T3 (pt)
IE (1) IE70519B1 (pt)
PT (1) PT94575B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2052602T3 (es) * 1986-10-03 1994-07-16 Ciba Geigy Ag Nuevos peptidos afines a las linfocinas.
ATE311895T1 (de) 1992-05-26 2005-12-15 Immunex Corp Neue zytokine die cd30 binden
US6645493B1 (en) * 1993-05-17 2003-11-11 The Picower Institute For Medical Research Composition containing anti-MIF antibody
US6774227B1 (en) * 1993-05-17 2004-08-10 Cytokine Pharmasciences, Inc. Therapeutic uses of factors which inhibit or neutralize MIF activity
UY27304A1 (es) 2001-05-24 2002-12-31 Avanir Pharmaceuticals Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación
TW200418829A (en) 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
CN1839133A (zh) * 2003-08-22 2006-09-27 阿文尼尔药品公司 作为巨噬细胞移动抑制因子的抑制剂的取代的二氮杂萘衍生物及其在治疗人类疾病中的应用
WO2006068398A1 (en) 2004-12-20 2006-06-29 Isu Abxis Co., Ltd. Molecules inhibition intercellular adhesion
US7740856B2 (en) * 2005-12-20 2010-06-22 Isu Abxis Co., Ltd. Effect of BST2 on inflammation
US8329186B2 (en) * 2004-12-20 2012-12-11 Isu Abxis Co., Ltd Treatment of inflammation using BST2 inhibitor
US20080299128A1 (en) * 2006-06-20 2008-12-04 Myung Kim Effect of Bst2 on inflammation
WO2006102191A1 (en) * 2005-03-24 2006-09-28 Avanir Pharmaceuticals Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
MXPA05011139A (es) * 2005-10-17 2007-04-17 Concretos Translucidos S De R Formulacion para obtener una mezcla de concreto conductivo.
GB0605689D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
US9249217B2 (en) * 2010-12-03 2016-02-02 Secretary, DHHS Bispecific EGFRvIII x CD3 antibody engaging molecules
US9958456B2 (en) 2011-10-07 2018-05-01 Baxalta Incorporated OxMIF as a diagnostic marker

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0672158B2 (ja) * 1984-05-24 1994-09-14 チバ−ガイギ− アクチエンゲゼルシヤフト 精製されたヒトマクロファージ遊走阻止因子
US5008374A (en) * 1986-03-14 1991-04-16 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and drugs
ES2052602T3 (es) * 1986-10-03 1994-07-16 Ciba Geigy Ag Nuevos peptidos afines a las linfocinas.
ATE149176T1 (de) * 1987-10-02 1997-03-15 Univ Rockefeller Von makrophagen abstammender entzündungsvermittler(mip-1-alpha et mip-1-beta)

Also Published As

Publication number Publication date
JPH0356499A (ja) 1991-03-12
AU5809590A (en) 1991-01-10
PT94575B (pt) 1997-02-28
ATE131873T1 (de) 1996-01-15
EP0412050A1 (en) 1991-02-06
IE70519B1 (en) 1996-12-11
IE902426A1 (en) 1991-06-19
ES2081960T3 (es) 1996-03-16
DE69024279T2 (de) 1996-10-17
DD298948A5 (de) 1992-03-19
AU649226B2 (en) 1994-05-19
GB8915414D0 (en) 1989-08-23
GR3018521T3 (en) 1996-03-31
DE69024279D1 (de) 1996-02-01
EP0412050B1 (en) 1995-12-20
US5411882A (en) 1995-05-02
US5821336A (en) 1998-10-13
DK0412050T3 (da) 1996-01-29
CA2020303A1 (en) 1991-01-06

Similar Documents

Publication Publication Date Title
PT94575A (pt) Processo para a preparacao de novas citoquinas
WO1990010709A3 (en) Monoclonal antibodies for metallic cations on small molecules
PT868519E (pt) Diagnostico e tratamento de disturbios relacionados com aur-1 e/ou aur-2
NO962560L (no) Materialer og metoder ved påvisning av stpahylococcus aureus
CY1109093T1 (el) Πρωτεϊνες των υποδοχεων θηλαστικων, σχετικα αντιδραστηρια και σχετικες μεθοδοι
WO1991006866A3 (en) Urinary tumor associated antigen, antigenic subunits uses and methods of detection
NO155768C (no) Fremgangsmaate for fremstilling av mineralfibre ved sentrifugering.
DE69419966D1 (de) Impstoff gegen Streptococcus suis-Infektion
AU6421490A (en) Means for diagnosing demyelinating neuropathies, in particular multiple sclerosis
IT1121915B (it) Procedimento,per la realizzazione di riflettore ottico e particolarmente per proiettore d'automobile e macchina per la sua messa in opera
KR900701318A (ko) 항-사람 고분자량- 흑색종 관련 항원에 대한 항-이디오 타입 항체
HUT52819A (en) Process for producing polypeptides suitable for diagnosing mycoplasmic contamination of swine, by way of recombinant dna technique
ES2131066T3 (es) Vacuna de conjugacion de oligosacarido con adhesina para hi(haemophilus influenzae).
IT1159983B (it) Composizione polimera vulcanizzabile procedimento per la sua preparazione e vulcanizzato ottenuto mediante rascaldamento di tale composizione
DK592086A (da) Humant conglutinin
Kubis et al. A rapid electrophoretic method for separating rabbit skeletal muscle myosin heavy chains at high resolution
ES2056919T3 (es) Anticuerpo monoclonal especifico para la fosfolipasa a2 pancreatica humana.
DE3570677D1 (en) Acino-foetal differentiation proteins associated with cancer of the pancreas, antiserum and monoclonal antibodies against these proteins and processes for their preparation
PT90963A (pt) Processo para a preparacao de uma sequencia de acido nucleico e/ou de um fragmento desta ultima que codifica para pelo menos uma proteina reconhecida pelos anticorpos anti-p30 de "toxoplasma gondii" e suas aplicacoes
SE8403929D0 (sv) Recombinant dna molecule, transformed microorganisms and process for producing penicillin v amidase
ATE132907T1 (de) Verfahren zur verbesserten herstellung von menschlichen antikörpern sowie hierzu benutzte zellen
IT8021725A0 (it) Disposizione per la regolazione dell'ampiezza luminosa di proiettori di autoveicoli.
FI893009A0 (fi) Yttre fastsaettningsanordning.
BR8904681A (pt) Uma linha de celulas de hibridoma,mutantes,anticorpos,processos para a preparacao de uma linha de celulas e para a preparacao de anticorpos e processo e agente para comprovacao imunologica de atrazina
ATE78513T1 (de) Immunoglobulin-a-rezeptor-protein (arp), sowie dessen klonierung und expression.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19900927

FG3A Patent granted, date of granting

Effective date: 19961127

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20000531